Mycobacterium - Drug effects
Research News and Information

Sunday, November 22, 2009

A renal tuberculosis case: could Chinese medicine play a role?

30 Jul 2009 CASE REPORT: A case of renal tuberculosis (TB) was treated with a multidrug therapeutic regimen (rifampicin 600 mg/day, ethambutol 800 mg/day, and isoniazid 150 mg/day), which was terminated for severe hepatotoxicity 2 months later. As an ... Read more...

Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.

29 Jun 2009 A set of 4-benzylsulfanylpyridine-2-carbohydrazides was synthesized and evaluated for in vitro antimycobacterial activity against Mycobacterium tuberculosis, non-tuberculous mycobacteria, and multidrug-resistant M. tuberculosis. The activities ... Read more...

Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria.

13 Jun 2009 Antibiotic resistance and virulence of pathogenic mycobacteria are phenotypically associated, but the underlying genetic linkage has not been known. Here we show that PknG, a eukaryotic-type protein kinase previously found to support survival of ... Read more...

Latest indexed articles for 'Mycobacterium - Drug effects'

These are the very latest articles for this heading:

• A renal tuberculosis case: could Chinese medicine play a role? 30 Jul 2009
• Divisive drug-resistance. 29 Jun 2009
• Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents. 29 Jun 2009
• Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria. 13 Jun 2009
• A balancing act: efflux/influx in mycobacterial drug resistance. 16 May 2009
• Mutations in rpoB and katG genes in Mycobacterium isolates from the Southeast of Mexico. 29 Apr 2009
• Pulmonary disease due to Mycobacterium arosiense, an easily misidentified pathogenic novel mycobacterium. 20 Apr 2009
• In vitro activity of thioridazine against mycobacteria. 3 Apr 2009
• Pacemaker surgical site infection caused by Mycobacterium goodii. 30 Mar 2009
• Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. 17 Mar 2009
• Lys17 in the 'lasso' peptide lariatin A is responsible for anti-mycobacterial activity. 12 Mar 2009
• Antimicrobial resistance in non-tuberculous mycobacteria in New South Wales, 2002-2008. 11 Mar 2009
• MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis. 27 Feb 2009
• Pristinamycin-inducible gene regulation in mycobacteria. 11 Feb 2009
• Effects of biocides and other metal removal fluid constituents on Mycobacterium immunogenum. 3 Feb 2009
• Mycobacterium bolletii respiratory infections. 30 Jan 2009
• N-benzylsalicylthioamides: highly active potential antituberculotics. 30 Jan 2009
• Efflux-mediated drug resistance in bacteria: an update. 30 Dec 2008
• [Study of the drug-sensitivity of nontuberculous mycobacteria] 30 Dec 2008
• Tuberculosis and immigrants: a SIMIT (Italian Society of Infectious Diseases) clinical, epidemiological multicentric research investigation. 30 Dec 2008

See a longer list of these articles.

Technical information about 'Mycobacterium'

Definition: A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts.

Descriptor UI: D009161

Alternative terms: Mycobacterium;

Allowable Qualifiers: classification; cytology; drug effects; enzymology; genetics; growth & development; immunology; isolation & purification; metabolism; pathogenicity; physiology; radiation effects; ultrastructure; chemistry; virology;

Tree Number: B03.510.024.049.525.500; B03.510.460.400.410.552.552;

Technical Notes: general; prefer specifics; infection = MYCOBACTERIUM INFECTIONS; DF: MYCOBACT